@article{3854220e6ec446b29853429b3ff3a59d,
title = "Phase I Trial Results Testing Adoptively Transferred T Cells Expressing CD20-Specific Chimeric Antigen Receptors Containing CD28 and CD137 Costimulatory Domains In Patients with Mantle Cell Lymphoma and Indolent Lymphoma",
author = "Till, \{Brian G.\} and Jensen, \{Michael C.\} and Xiaojun Qian and Jinjuan Wang and Gopal, \{Ajay K\} and Maloney, \{David G.\} and Lindgren, \{Catherine G.\} and Yukang Lin and Pagel, \{John M.\} and Budde, \{Lihua E\} and Andrew Raubitschek and Stephen Forman and Philip Greenberg and Riddell, \{Stanley R.\} and Press, \{Oliver W.\}",
note = "Abstract 561 Background: Mantle cell lymphoma and indolent B cell lymphomas are incurable with chemotherapy but are susceptible to the T cell-mediated graft-versus-lymphoma effect of allogeneic hematopoietic cell transplantation (HCT). However, HCT is associated with high treatment-related morbidity and mortality, and furthermore, many patients are not eligible due to age, comorbidities, and lack of a suitable donor.",
year = "2010",
month = nov,
day = "19",
language = "American English",
volume = "116",
journal = "Blood",
}